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EFFECTIVE EXPERIENCE SHARING FOR IMPLEMENTATION REVIEW
MECHANISM OF ANTI-TB DRUGS SHARE
Shu-Chen Chang a, Yi-Fang Lee a, LI-Hsiang Su a, Chin-Chou Wang b.
aCommittee of Hospital Infection Control, Chang Gung Memorial Hospital-
Kaohsiung Medical Center, Kaohsiung, Taiwan; bDivision of Pulmonary
Diseases of Department of Internal Medicine, Chang Gung Memorial
Hospital-Kaohsiung Medical Center, Kaohsiung, Taiwan
Purpose: Tuberculosis is contagious diseases due to air-borne droplet. If the
patient has not administered properly complete treatment, not only delay
the patient’s condition, but also increase the chances of the spread of tuber-
culosis bacteria. Drug medication treatment is still the main treatment for
tuberculosis. Standard regimen is included drug treatment for at least six
months in four anti-tuberculosis drug treatment regimens.
Methods: Kaohsiung Chang Gung Memorial Hospital is the largest medical
center in southern Taiwan; there are approximately 600 to 800 newly diag-
nosed TB patients every year. To facilitate the standardization of patients
receiving anti-TB drugs prescribed, the tuberculosis patients control group
developed an anti-TB drugs review mechanism. First, Chest and Infection
specialist physician will hospital-widely review all tuberculosis cases of
anti-TB drugs medication; if there were doubt about medication recommen-
dations, the patient’s attending physician the invited to discuss in tubercu-
losis control group meetings; such as meeting the suspect again raised to
disease management department will review cases. Also features a two-
way feedback mechanism.
Results: After this review mechanism,court of TB diagnosis and treatment of
druguse in linewith theguidelines from2011 to 2013 increased from69% to88%.Conclusions: The use of the drug test and two-way feedback mechanism,
provide immediate diagnosis and treatment of physician reference standard-
ized treatment, provided TB proper medical treatment, not just treat pa-
tients, and reduce the chance of spread of TB.PS 1-224
FALSE-POSITIVE RESULT OF QUANTITATIVE PCR (XPERT MTB/RIF) FOR
MYCOBACTERIUM KANSASII PNEUMONIA: A CASE REPORT
Shu-Ching Hsu a, Wen-Liang Yu b. aInfection Control Committee, Chi-Mei
Medical Center, Tainan, Taiwan; bDepartment of Intensive Care Medicine,
Chi-Mei Medical Center, Tainan, Taiwan
Purpose: Mycobacterium kansasii causes serious pulmonary disease usually
in patients with human immunodeficiency virus (HIV) infection. Xpert
MTB/RIF is an automated real-time PCR system that detects tuberculosis
(TB) and resistance to rifampicin. We report a non-HIV patient with M. kan-
saii pneumonia who had false-positive Xpert MTB tests.
Case Report: The 68 y/o man has past history of old TB post thoracotomy
and chemotherapy about 7-8 years ago. He had cough, whitish sputum and
dyspnea for one month. Fever episode was noted. There was no chest
pain, nausea or vomiting. Upon emergency room, his consciousness was clear
and the vital signs showed a body temperature of 37.9 degree Celsius, a
heart rate of 112 bpm, a respiratory rate of 28 breaths per minute and a
blood pressure of 117/73 mmHg. On physical examination, the breath sounds
were bilateral coarse rales. Laboratory data showed elevated C-reactive
protein. CXR showed airspace infiltration at bilateral lower lung fields with
compensatory emphysematous change at right lower lung, in favor of
chronic infectious process. He was admitted on December 5, 2013. For pneu-
monia treatment, empiric antibiotics with piperacillin-tazobactam and min-
ocycline were given followed by piperacillin and levofloxacin whenpneumonia improved. The sputum acid-fast stains were positive and the
sputum Xpert MTB/RIF test showed a positive TB finding (102w103 CFU/
mL) without rifampin resistance. Thus, he was transferred to the isolation
room and received anti-TB treatment with Rifater and ethambutol. His con-
dition slowly improved. However, the TB cultures yielded M. kansasii for
sputum specimens obtained on December 5, 9 and 12, 2013.
Conclusions: Unlike other nontuberculous mycobacteria, M. kansasii is
believed to rarely represent colonization or an environmental contaminant.
PCR with specific nucleic acid probes is useful for early identification of
growing M kansasii colonies. However, M. kansasii pneumonia can present
a false-positive Xpert MTB test in a non-HIV patient.PS 1-225
EVALUATION OF NON-TUBERCULOUS MYCOBACTERIAL SPECIES
DISTRIBUTION TO ENHANCE INFECTION CONTROL
Yi Shun. Chen a, Hui Min. Fan a, Lih Yu. Chang b, Ruo Ying. Wu a, Ya
I. Hsiao a. aLaboratory Medicine Department, National Taiwan University
Hospital Hsin-Chu Branch, Taiwan; bDivision of Chest, National Taiwan
University Hospital Hsin-Chu Branch, Taiwan
Purpose: Since the policy of “Halving TB in 10 years program” was promoted
by Taiwan CDC in 2005, tuberculosis has been closely monitored，but the
trend of prevalence about non-tuberculosis mycobacterium（NTM）associ-
ated diseases increases gradually. The course of anti-NTM treatment ,which
usually needs 18 months, is longer than that（6-9 months）of anti-TB regi-
ments. Besides, anti-NTM therapy panels vary with each infected NTM spe-
cies，which differs from the direct application of treatment guideline for
TB. Therefore, laboratory accurate NTM identification reports and species
distribution analysis could decrease the events of misdiagnosed TB and
help the clinicians make adequate anti-NTM regiments.
Methods: 7621 clinical specimens (from Jun., 2013 to Jun., 2014) were
collected and examined, according to the guidelines of Manual for Labora-
tory Mycobacterial Diagnosis (Taiwan CDC,2004); isolated mycobacteria
were further differentiated between MTB and NTM by Immuno-chromatog-
raphy. The distribution of NTM species was analyzed (single NTM /different
kinds of NTM/combined with TB).
Results: Among 320 specimenswith positive acid-fast-stain, about 20.6% showed
NTM at final culture reports, meeting quality requirements(19%e36.7%;Taiwan
CDC, 2014). Total 221 NTM strains were isolated from 120 patients, with 7.5％
co-cultured with MTB strains, 9.2％ combined with 2 NTM species, and 11.7％
converted-cultured after anti-TB regiments. The top three identified NTM spe-
cies, followed with respective isolation rate: MAC (43.9%)、M. kansasii (19%)、
M . abscessus (15.4 %), accounting for 78.3% of all NTM.
Conclusions: The water supply system of hospital is usually the main source
of transmission of certain NTM species. By analysis of NTM species identifica-
tion & distribution, not only the clinicians could in-time exclude the cases
suspected as tuberculosis, but it would be of great benefit on effective
treatment, medical resource utility, public health implementation and
infection control of NTM diseases.PS 1-226
MEASLES SEROPREVALENCE AND REVACCINATION EFFICACY AMONG
HEALTHCARE WORKERS IN SOUTHERN TAIWAN
Tzong-Shiann Ho a, Li-Rong Wang b, Shih-Min Wang a, Ching-Chuan Liu b,c.
aDepartment of Emergency Medicine, National Cheng Kung University
Hospital, College of Medicine, National Cheng Kung University, Tainan,
Taiwan; bCenter for Infection Control, National Cheng Kung University
Hospital, College of Medicine, National Cheng Kung University, Tainan,
Taiwan; cDepartment of Pediatrics, National Cheng Kung University
Hospital, College of Medicine, National Cheng Kung University, Tainan,
Taiwan
Purpose: Measles is a serious infectious disease globally despite the exis-
tence of effective vaccines. Waning measles immunity in healthcare workers
(HCWs) poses new challenges in infection control. This study aimed to deter-
mine the current measles seroprevalence and revaccination efficacy
amongst HCWs in southern Taiwan.
Methods: A measles seroprevalence survey on all newly recruited HCWs at a
university hospital in southern Taiwan between 2007 and 2013 was conduct-
ed using enzyme-linked immunosorbent assays (Enzygnost(R) test kit,
